1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 ALA D 2 - CYS D 3 MODEL 1 OMEGA = 0.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION ALA C 2 - CYS C 3 MODEL 2 OMEGA = 0.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION ALA D 2 - CYS D 3 MODEL 3 OMEGA = 0.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION ALA D 2 - CYS D 3 MODEL 4 OMEGA = 359.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION SER C 1 IS A D-SERINE. SER D 1 IS A D-SERINE. Chen, H. Patel, D.J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H11 N O2 129.157 2-METHYL-1-METHYLAMINO-CYCLOPROPANE CARBOXYLIC ACID L-peptide linking C10 H14 N5 O6 P 331.222 y 2'-DEOXYADENOSINE-5'-MONOPHOSPHATE DNA linking C9 H14 N3 O7 P 307.197 y 2'-DEOXYCYTIDINE-5'-MONOPHOSPHATE DNA linking C10 H14 N5 O7 P 347.221 y 2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE DNA linking C3 H7 N O3 105.093 D-SERINE D-peptide linking C10 H15 N2 O8 P 322.208 y THYMIDINE-5'-MONOPHOSPHATE DNA linking C10 H7 N O3 189.167 3-HYDROXYQUINALDIC ACID non-polymer C4 H9 N O2 S 135.185 N-METHYLCYSTEINE L-peptide linking C8 H17 N O2 S 191.291 n N-METHYL-S-[(1R)-1-METHYLPROPYL]-L-CYSTEINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 246 164 10.1006/JMBI.1994.0074 7853395 Solution Structure of a Quinomycin Bisintercalator-DNA Complex. 1995 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 2426.617 DNA (5'-D(*AP*CP*AP*CP*GP*TP*GP*T)-3') 2 syn polymer 847.056 QUINOMYCIN 1 syn polymer 189.167 3-HYDROXYQUINALDIC ACID 2 syn non-polymer QUINOMYCIN A, UK-63052 no no (DA)(DC)(DA)(DC)(DG)(DT)(DG)(DT) ACACGTGT A,B polydeoxyribonucleotide no yes (DSN)A(NYB)(CPC)(DSN)A(NCY)(CPC) SAXXSAXX C polypeptide(L) n n n n n n n n n n n n n n n n -20.633 1 20 A 1 B 8 -1.999 A_DA1:DT8_B 1 -17.637 -0.006 -0.134 -0.210 -17.459 1 19 A 2 B 7 -1.260 A_DC2:DG7_B 2 -0.855 0.561 0.357 -0.284 9.576 1 20 A 3 B 6 -2.211 A_DA3:DT6_B 3 -1.872 0.436 0.197 -0.145 -21.667 1 19 A 4 B 5 0.200 A_DC4:DG5_B 4 5.574 0.957 0.495 -0.358 20.252 1 19 A 5 B 4 -4.361 A_DG5:DC4_B 5 1.744 -0.632 0.355 -0.317 -6.019 1 20 A 6 B 3 0.338 A_DT6:DA3_B 6 -0.421 -0.348 0.256 -0.221 16.481 1 19 A 7 B 2 -1.791 A_DG7:DC2_B 7 1.863 -0.474 0.181 -0.281 26.186 1 20 A 8 B 1 -1.220 A_DT8:DA1_B 8 -14.958 -0.025 -0.331 -0.167 3.182 30.174 A A 1 2 6.511 B B 8 7 3.271 3.381 -0.570 -0.857 AA_DA1DC2:DG7DT8_BB 1 -1.514 2.915 29.951 -2.327 0.791 1.661 24.502 A A 2 3 25.384 B B 7 6 2.364 10.435 -0.102 -1.133 AA_DC2DA3:DT6DG7_BB 2 1.121 -2.727 22.172 -4.761 0.466 7.256 22.863 A A 3 4 11.035 B B 6 5 7.172 4.317 0.664 1.223 AA_DA3DC4:DG5DT6_BB 3 4.711 -12.041 21.964 -0.377 2.102 -1.245 3.286 A A 4 5 -60.162 B B 5 4 2.438 -2.839 -0.191 2.795 AA_DC4DG5:DC4DG5_BB 4 0.392 -8.303 1.607 60.805 4.988 6.800 23.146 A A 5 6 5.826 B B 4 3 6.967 2.267 -0.847 1.216 AA_DG5DT6:DA3DC4_BB 5 -9.428 24.227 21.042 1.291 -5.124 1.957 23.147 A A 6 7 18.180 B B 3 2 2.456 7.177 -0.161 -1.231 AA_DT6DG7:DC2DA3_BB 6 0.441 -1.116 22.017 -4.794 0.508 3.022 29.114 A A 7 8 1.424 B B 2 1 3.014 0.716 0.756 -0.929 AA_DG7DT8:DA1DC2_BB 7 1.385 -2.757 29.073 -1.993 -1.224 atom_site pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list pdbx_validate_polymer_linkage repository Initial release Version format compliance Version format compliance Atomic model Database references Derived calculations Non-polymer description Structure summary Other Advisory Atomic model Derived calculations Other 1 0 1995-02-27 1 1 2011-06-14 1 2 2011-07-13 1 3 2011-07-27 1 4 2012-12-12 2 0 2017-11-01 _atom_site.auth_atom_id _atom_site.label_atom_id _pdbx_database_status.process_site _pdbx_struct_assembly.details _pdbx_struct_assembly.method_details _pdbx_struct_oper_list.symmetry_operation SOLUTION STRUCTURE OF D(GACGTC) COMPLEXED WITH TRIOSTIN A CRYSTAL STRUCTURE OF D(GCGTACG) COMPLEXED WITH ECHINOMYCIN - SPACE GROUP P6322 CRYSTAL STRUCTURE OF D(GCGTACGC) COMPLEXED WITH TRIOSIN A CRYSTAL STRUCTURE OF D(GCGTACGC) COMPLEXED WITH ECHINOMYCIN - SPACE GROUP P632 CRYSTAL STRUCTURE OF D(ACGTACGT) COMPLEXED WITH ECHINOMYCIN - SPACE GROUP P632 CRYSTAL STRUCTURE OF D(CGTACG) COMPLEXED WITH ECHINOMYCIN - SPACE GROUP C21 CRYSTAL STRUCTURE OF D(ACGTACGT) COMPLEXED WITH ECHINOMYCIN - SPACE GROUP P42212 SOLUTION STRUCTURE OF D(GATATC) COMPLEXED WITH A MODIFIED TRIOSTIN A AT POSITIONS 4 AND 8 CRYSTAL STRUCTURE OF D(ACGTACGT) COMPLEXED WITH ECHINOMYCIN - SPACE GROUP P41212 Y BNL 1994-09-30 REL HQU 3-HYDROXYQUINALDIC ACID CHEMICALLY SYNTHESIZED sample CHEMICALLY SYNTHESIZED STREPTOMYCES sample QUINOMYCIN UK63052 IS A BICYCLIC OCTADEPSIPEPTIDE, A MEMBER OF THE QUINOXALINE CLASS OF ANTIBIOTICS. HERE, QUINOMYCIN IS REPRESENTED BY GROUPING TOGETHER THE SEQUENCE (SEQRES) AND THE TWO LIGANDS (HET) HQU Antibiotic QUINOMYCIN UK63052 IS A BICYCLIC OCTADEPSIPEPTIDE. BICYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI, AND A THIOACETAL BOND BETWEEN RESIDUES 3 AND 7. THE TWO HYDROXYQUINOXALINE CHROMOPHORES ARE LINKED TO THE D-SERINE RESIDUES, RESIDUES 1 AND 5. uk63052 Cyclic depsipeptide all calculated structures submitted 4 4 TWO STARTING STRUCTURES WERE GENERATED BY MANUALLY DOCKING THE DRUG ONTO A- AND B-FORM DNA USING INSIGHT II AND WERE SUBSEQUENTLY REFINED BY DISTANCE- RESTRAINED MOLECULAR DYNAMICS USING A SET OF INTER-PROTON DISTANCE RESTRAINTS DERIVED FROM THE NMR DATA. TWO INITIAL VELOCITY SEEDS WERE USED FOR EACH STARTING STRUCTURE WHICH YIELDS FOUR DISTANCE-REFINED STRUCTURES. THEY WERE REFINED FURTHER USING RELAXATION-MATRIX BASED NOE INTENSITY-RESTRAINED MOLECULAR DYNAMICS. THE FINAL FOUR STRUCTURES WERE OBTAINED BY TAKING THE AVERAGE COORDINATES OF THE LAST 0.5 PS OF THE DYNAMICS DURING RELAXATION MATRIX REFINEMENT AND ENERGY MINIMIZED. THE R(1/6) VALUE WAS USED TO REFINE THE STRUCTURE DURING RELAXATION MATRIX REFINEMENT. THE SUMMATIONS RUN THROUGH ALL OBSERVED, QUANTIFIABLE NOE CROSSPEAKS IN NOESY SPECTRA RECORDED IN D2O AND MIXING TIMES OF 30, 60, 120 AND 180 MS. THE R(1/6) FACTOR AND THE RMS DEVIATIONS FROM IDEAL GEOMETRY FOR THE FOUR FINAL STRUCTURES ARE: MODEL1 MODEL2 MODEL3 MODEL4 R(1/6) FACTOR 0.023 0.024 0.024 0.026 BOND (ANG) 0.011 0.011 0.011 0.011 ANGLES (DEG) 3.616 3.657 3.700 3.725 IMPROPERS (DEG) 0.274 0.285 0.241 0.298 MOLECULAR DYNAMICS, MATRIX RELAXATION D2O BRUNGER refinement X-PLOR HQU 0 3 HQU HQU 0 C HQU 9 3 HQU HQU 9 C DA 1 n 1 DA 1 A DC 2 n 2 DC 2 A DA 3 n 3 DA 3 A DC 4 n 4 DC 4 A DG 5 n 5 DG 5 A DT 6 n 6 DT 6 A DG 7 n 7 DG 7 A DT 8 n 8 DT 8 A DA 1 n 1 DA 1 B DC 2 n 2 DC 2 B DA 3 n 3 DA 3 B DC 4 n 4 DC 4 B DG 5 n 5 DG 5 B DT 6 n 6 DT 6 B DG 7 n 7 DG 7 B DT 8 n 8 DT 8 B DSN 1 n 1 DSN 1 C ALA 2 n 2 ALA 2 C NYB 3 n 3 NYB 3 C CPC 4 n 4 CPC 4 C DSN 5 n 5 DSN 5 C ALA 6 n 6 ALA 6 C NCY 7 n 7 NCY 7 C CPC 8 n 8 CPC 8 C author_defined_assembly 3 trimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 1 4.29 0.50 113.80 118.09 A A A N7 C8 N9 DA DA DA 1 1 1 N 1 -4.24 0.70 108.00 103.76 A A A O4' C1' N1 DC DC DC 2 2 2 N 1 -5.43 0.80 105.90 100.47 A A A O4' C1' C2' DG DG DG 5 5 5 N 1 3.17 0.50 113.10 116.27 A A A N7 C8 N9 DG DG DG 5 5 5 N 1 -2.53 0.40 106.40 103.87 A A A C8 N9 C4 DG DG DG 5 5 5 N 1 2.46 0.30 108.30 110.76 A A A O4' C1' N1 DT DT DT 6 6 6 N 1 -4.44 0.60 122.90 118.46 A A A C6 C5 C7 DT DT DT 6 6 6 N 1 2.72 0.30 108.30 111.03 A A A O4' C1' N9 DG DG DG 7 7 7 N 1 3.09 0.50 113.10 116.19 A A A N7 C8 N9 DG DG DG 7 7 7 N 1 2.25 0.30 108.30 110.55 A A A O4' C1' N1 DT DT DT 8 8 8 N 1 4.16 0.50 113.80 117.96 B B B N7 C8 N9 DA DA DA 1 1 1 N 1 3.63 0.60 118.90 122.53 B B B N1 C2 O2 DC DC DC 2 2 2 N 1 7.58 1.20 119.70 127.28 B B B C3' O3' P DC DC DA 2 2 3 Y 1 2.48 0.30 108.30 110.78 B B B O4' C1' N1 DC DC DC 4 4 4 N 1 4.14 0.60 118.90 123.04 B B B N1 C2 O2 DC DC DC 4 4 4 N 1 -6.55 1.00 110.10 103.55 B B B C1' O4' C4' DT DT DT 6 6 6 N 1 4.97 0.30 108.30 113.27 B B B O4' C1' N1 DT DT DT 6 6 6 N 1 2.72 0.30 108.30 111.02 B B B O4' C1' N9 DG DG DG 7 7 7 N 1 3.02 0.50 113.10 116.12 B B B N7 C8 N9 DG DG DG 7 7 7 N 1 2.41 0.30 108.30 110.71 B B B O4' C1' N1 DT DT DT 8 8 8 N 2 4.21 0.50 113.80 118.01 A A A N7 C8 N9 DA DA DA 1 1 1 N 2 -4.21 0.70 108.00 103.79 A A A O4' C1' N1 DC DC DC 2 2 2 N 2 8.56 1.20 119.70 128.26 A A A C3' O3' P DC DC DA 2 2 3 Y 2 3.49 0.30 108.30 111.79 A A A O4' C1' N1 DC DC DC 4 4 4 N 2 4.06 0.60 118.90 122.96 A A A N1 C2 O2 DC DC DC 4 4 4 N 2 3.51 0.50 113.10 116.61 A A A N7 C8 N9 DG DG DG 5 5 5 N 2 -2.73 0.40 106.40 103.67 A A A C8 N9 C4 DG DG DG 5 5 5 N 2 1.93 0.30 108.30 110.23 A A A O4' C1' N9 DG DG DG 7 7 7 N 2 3.28 0.50 113.10 116.38 A A A N7 C8 N9 DG DG DG 7 7 7 N 2 -2.43 0.40 106.40 103.97 A A A C8 N9 C4 DG DG DG 7 7 7 N 2 3.16 0.30 108.30 111.46 A A A O4' C1' N1 DT DT DT 8 8 8 N 2 -3.05 0.50 103.90 100.85 B B B C5 N7 C8 DA DA DA 1 1 1 N 2 4.39 0.50 113.80 118.19 B B B N7 C8 N9 DA DA DA 1 1 1 N 2 7.24 1.20 115.70 122.94 B B B C5' C4' C3' DC DC DC 2 2 2 N 2 -4.29 0.70 108.00 103.71 B B B O4' C1' N1 DC DC DC 2 2 2 N 2 9.76 1.20 119.70 129.46 B B B C3' O3' P DC DC DA 2 2 3 Y 2 4.65 0.30 108.30 112.95 B B B O4' C1' N9 DA DA DA 3 3 3 N 2 5.39 0.30 108.30 113.69 B B B O4' C1' N1 DC DC DC 4 4 4 N 2 3.93 0.60 118.90 122.83 B B B N1 C2 O2 DC DC DC 4 4 4 N 2 3.63 0.30 108.30 111.93 B B B O4' C1' N9 DG DG DG 5 5 5 N 2 2.62 0.30 108.30 110.92 B B B O4' C1' N1 DT DT DT 6 6 6 N 2 1.97 0.30 108.30 110.27 B B B O4' C1' N9 DG DG DG 7 7 7 N 2 3.24 0.50 113.10 116.34 B B B N7 C8 N9 DG DG DG 7 7 7 N 2 -2.41 0.40 106.40 103.99 B B B C8 N9 C4 DG DG DG 7 7 7 N 2 3.35 0.30 108.30 111.65 B B B O4' C1' N1 DT DT DT 8 8 8 N 3 4.17 0.30 108.30 112.47 A A A O4' C1' N9 DA DA DA 1 1 1 N 3 -3.08 0.50 103.90 100.82 A A A C5 N7 C8 DA DA DA 1 1 1 N 3 4.60 0.50 113.80 118.40 A A A N7 C8 N9 DA DA DA 1 1 1 N 3 -4.66 0.70 108.00 103.34 A A A O4' C1' N1 DC DC DC 2 2 2 N 3 4.20 0.60 118.90 123.10 A A A N1 C2 O2 DC DC DC 2 2 2 N 3 -5.03 0.80 105.90 100.87 A A A O4' C1' C2' DA DA DA 3 3 3 N 3 2.58 0.30 108.30 110.88 A A A O4' C1' N9 DA DA DA 3 3 3 N 3 3.86 0.60 118.90 122.76 A A A N1 C2 O2 DC DC DC 4 4 4 N 3 10.01 1.20 119.70 129.71 A A A C3' O3' P DC DC DG 4 4 5 Y 3 3.36 0.50 113.10 116.46 A A A N7 C8 N9 DG DG DG 5 5 5 N 3 -2.68 0.40 106.40 103.72 A A A C8 N9 C4 DG DG DG 5 5 5 N 3 -3.84 0.60 122.90 119.06 A A A C6 C5 C7 DT DT DT 6 6 6 N 3 2.72 0.30 108.30 111.02 A A A O4' C1' N9 DG DG DG 7 7 7 N 3 3.49 0.50 113.10 116.59 A A A N7 C8 N9 DG DG DG 7 7 7 N 3 -2.41 0.40 106.40 103.99 A A A C8 N9 C4 DG DG DG 7 7 7 N 3 2.42 0.30 108.30 110.72 A A A O4' C1' N1 DT DT DT 8 8 8 N 3 4.27 0.30 108.30 112.57 B B B O4' C1' N9 DA DA DA 1 1 1 N 3 -3.06 0.50 103.90 100.84 B B B C5 N7 C8 DA DA DA 1 1 1 N 3 4.63 0.50 113.80 118.43 B B B N7 C8 N9 DA DA DA 1 1 1 N 3 -4.77 0.70 108.00 103.23 B B B O4' C1' N1 DC DC DC 2 2 2 N 3 4.18 0.60 118.90 123.08 B B B N1 C2 O2 DC DC DC 2 2 2 N 3 4.03 0.60 118.90 122.93 B B B N1 C2 O2 DC DC DC 4 4 4 N 3 3.16 0.50 113.10 116.26 B B B N7 C8 N9 DG DG DG 5 5 5 N 3 -2.73 0.40 106.40 103.67 B B B C8 N9 C4 DG DG DG 5 5 5 N 3 3.98 0.30 108.30 112.28 B B B O4' C1' N1 DT DT DT 6 6 6 N 3 -3.98 0.60 122.90 118.92 B B B C6 C5 C7 DT DT DT 6 6 6 N 3 2.75 0.30 108.30 111.05 B B B O4' C1' N9 DG DG DG 7 7 7 N 3 3.54 0.50 113.10 116.64 B B B N7 C8 N9 DG DG DG 7 7 7 N 3 -2.45 0.40 106.40 103.95 B B B C8 N9 C4 DG DG DG 7 7 7 N 3 2.22 0.30 108.30 110.52 B B B O4' C1' N1 DT DT DT 8 8 8 N 4 2.31 0.30 108.30 110.61 A A A O4' C1' N9 DA DA DA 1 1 1 N 4 -3.10 0.50 103.90 100.80 A A A C5 N7 C8 DA DA DA 1 1 1 N 4 4.44 0.50 113.80 118.24 A A A N7 C8 N9 DA DA DA 1 1 1 N 4 7.25 1.20 115.70 122.95 A A A C5' C4' C3' DC DC DC 2 2 2 N 4 -7.37 0.70 108.00 100.63 A A A O4' C1' N1 DC DC DC 2 2 2 N 4 8.55 1.20 119.70 128.25 A A A C3' O3' P DC DC DA 2 2 3 Y 4 4.06 0.30 108.30 112.36 A A A O4' C1' N9 DA DA DA 3 3 3 N 4 3.81 0.60 118.90 122.71 A A A N1 C2 O2 DC DC DC 4 4 4 N 4 3.38 0.50 113.10 116.48 A A A N7 C8 N9 DG DG DG 5 5 5 N 4 -2.77 0.40 106.40 103.63 A A A C8 N9 C4 DG DG DG 5 5 5 N 4 -5.35 0.80 105.90 100.55 A A A O4' C1' C2' DT DT DT 6 6 6 N 4 7.28 0.30 108.30 115.58 A A A O4' C1' N9 DG DG DG 7 7 7 N 4 9.89 1.10 109.80 119.69 A A A C5' C4' O4' DT DT DT 8 8 8 N 4 2.48 0.30 108.30 110.78 B B B O4' C1' N9 DA DA DA 1 1 1 N 4 4.27 0.50 113.80 118.07 B B B N7 C8 N9 DA DA DA 1 1 1 N 4 3.79 0.60 106.00 109.79 B B B O4' C4' C3' DC DC DC 2 2 2 N 4 -7.52 0.70 108.00 100.48 B B B O4' C1' N1 DC DC DC 2 2 2 N 4 7.02 0.30 108.30 115.32 B B B O4' C1' N9 DA DA DA 3 3 3 N 4 4.55 0.30 108.30 112.85 B B B O4' C1' N1 DC DC DC 4 4 4 N 4 1.90 0.30 108.30 110.20 B B B O4' C1' N9 DG DG DG 5 5 5 N 4 3.30 0.50 113.10 116.40 B B B N7 C8 N9 DG DG DG 5 5 5 N 4 -2.47 0.40 106.40 103.93 B B B C8 N9 C4 DG DG DG 5 5 5 N 4 3.23 0.30 108.30 111.53 B B B O4' C1' N1 DT DT DT 6 6 6 N 4 -4.38 0.60 122.90 118.52 B B B C6 C5 C7 DT DT DT 6 6 6 N 4 7.14 0.30 108.30 115.44 B B B O4' C1' N9 DG DG DG 7 7 7 N 4 9.47 1.10 109.80 119.27 B B B C5' C4' O4' DT DT DT 8 8 8 N 1 A A C8 N9 DA DA 1 1 -0.048 0.008 1.373 1.325 N 1 A A C5 C7 DT DT 8 8 0.040 0.006 1.496 1.536 N 1 B B C5 C7 DT DT 6 6 0.041 0.006 1.496 1.537 N 1 B B C5 C7 DT DT 8 8 0.039 0.006 1.496 1.535 N 2 A A C8 N9 DA DA 1 1 -0.049 0.008 1.373 1.324 N 2 B B C8 N9 DA DA 1 1 -0.048 0.008 1.373 1.325 N 2 B B C5 C7 DT DT 6 6 0.037 0.006 1.496 1.533 N 2 B B C5 C7 DT DT 8 8 0.038 0.006 1.496 1.534 N 3 A A C8 N9 DA DA 1 1 -0.050 0.008 1.373 1.323 N 3 A A C5 C7 DT DT 8 8 0.040 0.006 1.496 1.536 N 3 B B C8 N9 DA DA 1 1 -0.049 0.008 1.373 1.324 N 3 B B C5 C7 DT DT 8 8 0.041 0.006 1.496 1.537 N 4 A A C8 N9 DA DA 1 1 -0.053 0.008 1.373 1.320 N 4 B B C8 N9 DA DA 1 1 -0.051 0.008 1.373 1.322 N model building X-PLOR refinement X-PLOR phasing X-PLOR QUINOMYCIN/DNA Complex, 3-HYDROXYQUINALDIC ACID SOLUTION STRUCTURE OF A QUINOMYCIN BISINTERCALATOR-DNA COMPLEX 1 N N 1 N N 2 N N 3 N N 3 N N covale 1.312 C HQU 0 D C HQU 1_555 C DSN 1 C N DSN 1 1_555 covale 1.314 C DSN 1 C C DSN 1 1_555 C ALA 2 C N ALA 2 1_555 covale 1.386 C DSN 1 C OG DSN 1 1_555 C CPC 8 C C CPC 8 1_555 covale 1.333 C ALA 2 C C ALA 2 1_555 C NYB 3 C N NYB 3 1_555 covale 1.808 C NYB 3 C CB NYB 3 1_555 C NCY 7 C SG NCY 7 1_555 covale 1.332 C NYB 3 C C NYB 3 1_555 C CPC 4 C N CPC 4 1_555 covale 1.394 C CPC 4 C C CPC 4 1_555 C DSN 5 C OG DSN 5 1_555 covale 1.312 C DSN 5 C C DSN 5 1_555 C ALA 6 C N ALA 6 1_555 covale 1.313 C DSN 5 C N DSN 5 1_555 C HQU 9 E C HQU 1_555 covale 1.332 C ALA 6 C C ALA 6 1_555 C NCY 7 C N NCY 7 1_555 covale 1.326 C NCY 7 C C NCY 7 1_555 C CPC 8 C N CPC 8 1_555 hydrog WATSON-CRICK A DA 1 A N1 DA 1 1_555 B DT 8 B N3 DT 8 1_555 hydrog WATSON-CRICK A DA 1 A N6 DA 1 1_555 B DT 8 B O4 DT 8 1_555 hydrog WATSON-CRICK A DC 2 A N3 DC 2 1_555 B DG 7 B N1 DG 7 1_555 hydrog WATSON-CRICK A DC 2 A N4 DC 2 1_555 B DG 7 B O6 DG 7 1_555 hydrog WATSON-CRICK A DC 2 A O2 DC 2 1_555 B DG 7 B N2 DG 7 1_555 hydrog WATSON-CRICK A DA 3 A N1 DA 3 1_555 B DT 6 B N3 DT 6 1_555 hydrog WATSON-CRICK A DA 3 A N6 DA 3 1_555 B DT 6 B O4 DT 6 1_555 hydrog WATSON-CRICK A DC 4 A N3 DC 4 1_555 B DG 5 B N1 DG 5 1_555 hydrog WATSON-CRICK A DC 4 A N4 DC 4 1_555 B DG 5 B O6 DG 5 1_555 hydrog WATSON-CRICK A DC 4 A O2 DC 4 1_555 B DG 5 B N2 DG 5 1_555 hydrog WATSON-CRICK A DG 5 A N1 DG 5 1_555 B DC 4 B N3 DC 4 1_555 hydrog WATSON-CRICK A DG 5 A N2 DG 5 1_555 B DC 4 B O2 DC 4 1_555 hydrog WATSON-CRICK A DG 5 A O6 DG 5 1_555 B DC 4 B N4 DC 4 1_555 hydrog WATSON-CRICK A DT 6 A N3 DT 6 1_555 B DA 3 B N1 DA 3 1_555 hydrog WATSON-CRICK A DT 6 A O4 DT 6 1_555 B DA 3 B N6 DA 3 1_555 hydrog WATSON-CRICK A DG 7 A N1 DG 7 1_555 B DC 2 B N3 DC 2 1_555 hydrog WATSON-CRICK A DG 7 A N2 DG 7 1_555 B DC 2 B O2 DC 2 1_555 hydrog WATSON-CRICK A DG 7 A O6 DG 7 1_555 B DC 2 B N4 DC 2 1_555 hydrog WATSON-CRICK A DT 8 A N3 DT 8 1_555 B DA 1 B N1 DA 1 1_555 hydrog WATSON-CRICK A DT 8 A O4 DT 8 1_555 B DA 1 B N6 DA 1 1_555 DNA/ANTIBIOTIC BISINTERCALATOR, DEPSIPEPTIDE, QUINOXALINE, THIOACETAL, ANTIBIOTIC, ANTITUMOR, DNA-ANTIBIOTIC COMPLEX 193D PDB 1 193D 193D PDB 2 193D 1 8 193D 1 8 193D A 1 1 8 1 8 193D 1 8 193D B 1 1 8 1 8 193D 1 8 193D C 2 1 8 BINDING SITE FOR CHAIN C OF QUINOMYCIN Software 8 A DA 3 A DA 3 8 1_555 A DC 4 A DC 4 8 1_555 A DG 5 A DG 5 8 1_555 A DT 6 A DT 6 8 1_555 B DA 3 B DA 3 8 1_555 B DC 4 B DC 4 8 1_555 B DG 5 B DG 5 8 1_555 B DT 6 B DT 6 8 1_555 1 P 1